Company: INDP
Filing Date: 2025-07-01
Form Type: 8-K
Source: 0001641172-25-017283
Chunk: 5

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-07-01
Form: 8-K
Item: Item 9.01
Chunk 5
---
Item       Financial                 

(d)
Exhibits.

  Exhibit      Description                                                                                                                                                                                           
      No.                                                                                                                                                                                                            
     10.1      Form of Securities Purchase Agreement, dated as of June 12, 2025, between the Company and the investors signatory thereto (incorporated by reference to Exhibit 10.1 of the Company’s Current Rep...  
     10.2      Form of Convertible Promissory Note (incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K, filed on June 13, 2025)                                                   
     10.3      Form of Common Warrant (incorporated by reference to Exhibit 10.3 of the Company’s Current Report on Form 8-K, filed on June 13, 2025)                                                                
     10.4      Form of Placement Agent Agreement, dated as of May 9, 2025, by and between Indaptus Therapeutics, Inc. and Paulson Investment Company, LLC (incorporated by reference to Exhibit 10.4 of the Comp...  
     99.1      Press release, dated July 1, 2025                                                                                                                                                                     
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover                                                                                                                                                                                                 

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

Date:
July 1, 2025